Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro

  • Authors:
    • Thomas Gehrke
    • Agmal Scherzad
    • Stephan Hackenberg
    • Pascal Ickrath
    • Philipp Schendzielorz
    • Rudolf Hagen
    • Norbert Kleinsasser
  • View Affiliations

  • Published online on: July 10, 2017     https://doi.org/10.3892/ijo.2017.4071
  • Pages: 931-938
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Lipid-lowering statins as well as non-steroidal anti-inflammatory drugs (NSAIDs) have been reported to possess cancer-protective effects in many epidemiologic cohort studies. However, the underlying mechanisms of these findings are mostly unknown. To evaluate possible additive antitumor effects of statins and NSAIDs in vitro, PJ-41 and HLaC78 head and neck squamous cell carcinoma cells (HNSCC) were treated with 40 µM celecoxib, 50 µM simvastatin or a combination of both. Analysis of tumor viability, proliferation, apoptosis, cell cycle changes and secretion of interleukin-6 (IL-6) and interleukin-8 (IL-8) was conducted via MTT assay, Annexin V-propidium iodide test, cell cycle analysis, colony assay and enzyme-linked immunosorbent assay (ELISA). Celecoxib and simvastatin alone as well as a combined treatment showed a significant reduction in tumor cell viability, proliferation and secretion of IL-6 and IL-8 compared to the control group. The combined treatment even proved to have significantly greater effects. We postulate that simvastatin and celecoxib have additive antitumor effects on HNSCC in vitro, which warrants further investigation.
View Figures
View References

Related Articles

Journal Cover

September-2017
Volume 51 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gehrke T, Scherzad A, Hackenberg S, Ickrath P, Schendzielorz P, Hagen R and Kleinsasser N: Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro. Int J Oncol 51: 931-938, 2017.
APA
Gehrke, T., Scherzad, A., Hackenberg, S., Ickrath, P., Schendzielorz, P., Hagen, R., & Kleinsasser, N. (2017). Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro. International Journal of Oncology, 51, 931-938. https://doi.org/10.3892/ijo.2017.4071
MLA
Gehrke, T., Scherzad, A., Hackenberg, S., Ickrath, P., Schendzielorz, P., Hagen, R., Kleinsasser, N."Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro". International Journal of Oncology 51.3 (2017): 931-938.
Chicago
Gehrke, T., Scherzad, A., Hackenberg, S., Ickrath, P., Schendzielorz, P., Hagen, R., Kleinsasser, N."Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro". International Journal of Oncology 51, no. 3 (2017): 931-938. https://doi.org/10.3892/ijo.2017.4071